Search details
1.
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.
Cell
; 183(6): 1617-1633.e22, 2020 12 10.
Article
in English
| MEDLINE | ID: mdl-33259802
2.
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations.
N Engl J Med
; 389(12): 1108-1120, 2023 Sep 21.
Article
in English
| MEDLINE | ID: mdl-37733309
3.
Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement.
Med J Aust
; 220(10): 533-538, 2024 Jun 03.
Article
in English
| MEDLINE | ID: mdl-38699949
4.
Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS).
Genet Med
; 25(12): 100969, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37634128
5.
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement.
Med J Aust
; 216(6): 312-319, 2022 04 04.
Article
in English
| MEDLINE | ID: mdl-35201615
6.
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
Acta Neuropathol
; 141(5): 771-785, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33619588
7.
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
Acta Neuropathol
; 142(5): 841-857, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34417833
8.
Growth hormone and targeted oncological agents: Are we stopping children with brain tumours from reaching their true height potential?
J Paediatr Child Health
; 57(8): 1170-1174, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34114264
9.
Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns.
Acta Neuropathol
; 140(5): 765-776, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32895736
10.
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
Acta Neuropathol
; 139(2): 223-241, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31820118
11.
Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature.
J Neurooncol
; 147(3): 721-730, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32297094
12.
Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence.
Pediatr Blood Cancer
; 67(5): e28228, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32124552
13.
Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration.
Pediatr Blood Cancer
; 67(12): e28627, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32959992
14.
Personalised medicine in paediatric oncology: Ethical practice outside the clinical trial framework?
J Paediatr Child Health
; 55(1): 10-12, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30499210
15.
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.
Acta Neuropathol
; 136(2): 239-253, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29766299
16.
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.
Acta Neuropathol
; 133(1): 5-12, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27858204
17.
Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
Int J Cancer
; 138(2): 481-8, 2016 Jan 15.
Article
in English
| MEDLINE | ID: mdl-26235348
18.
Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.
J Neurooncol
; 128(2): 293-302, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26994902
19.
Central Diabetes Insipidus and Cisplatin-Induced Renal Salt Wasting Syndrome: A Challenging Combination.
Pediatr Blood Cancer
; 63(5): 925-7, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26928867
20.
Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.
Pediatr Blood Cancer
; 63(1): 17-20, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26207610